wangxiaojuan, wangqi, yanyunjun, lijia, zhanglei. Research progress on the mechanisms and intervention strategies of gut microbiota-mediated regulation of gut-vascular barrier permeability. 2026. biomedRxiv.202607.00026
Research progress on the mechanisms and intervention strategies of gut microbiota-mediated regulation of gut-vascular barrier permeability
Corresponding author: zhanglei, ldyy_lzhang@lzu.edu.cn
DOI: 10.12201/bmr.202607.00026
-
Abstract: The gut-vascular barrier (GVB) is a deep barrier structure located beneath the intestinal epithelial layer and is composed of intestinal mucosal microvascular endothelial cells, pericytes, the basement membrane, enteric glial cells, and other components. Unlike the conventional intestinal epithelial barrier, the GVB primarily regulates the transport of gut-derived substances into the portal vein and systemic circulation, while restricting the systemic translocation of bacteria, bacterial components, and harmful metabolites. It therefore plays a critical role in maintaining intestinal homeostasis, immune surveillance, and preventing the dissemination of gut-derived inflammation. Accumulating evidence indicates that gut microbiota and their metabolites regulate the structure and function of the GVB through multiple pathways. Microbe-associated molecules, including short-chain fatty acids (SCFAs), bile acids, tryptophan metabolites, and lipopolysaccharide, can act on signaling networks such as histone deacetylases (HDACs), FXR/TGR5, AhR, TLR4/NF-κB, and endothelial cytoskeletal remodeling, thereby influencing tight junction protein expression, endothelial inflammatory responses, and vascular permeability. GVB dysfunction has been implicated in various intestinal and extraintestinal diseases, including inflammatory bowel disease, fatty liver disease, liver cirrhosis, and neurodegenerative disorders. This review systematically summarizes the composition of the GVB, the mechanisms by which gut microbiota regulate GVB function, related diseases, and potential intervention strategies. It aims to provide a new theoretical perspective on the interactions between gut microbiota and the host circulatory system, as well as a reference for the prevention and treatment of diseases associated with intestinal barrier dysfunction.
Key words: Gut-vascular barrier; Gut microbiota; Intestinal permeability; Microbial metabolites; Vascular endothelial cells; Intervention strategiesSubmit time: 19 July 2026
Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity. -
图表
-
zhangjun, zhanghongwei. The Latest Research Progress on Gestational Diabetes Mellitus and Gut Microbiota. 2025. doi: 10.12201/bmr.202509.00071
Bai Xue. Interaction between gut microbiota imbalance and neuroinflammation in Parkinsons disease overactive bladder syndrome. 2025. doi: 10.12201/bmr.202503.00017
唐柠峥, zhangfu. Exploring the Role of Gut Microbiota in the Pathogenesis of Hypertension Based on the. 2025. doi: 10.12201/bmr.202512.00041
Qin Chao. Progress in the study of the effect of intestinal microecological changes on the prognosis of elderly sepsis patients. 2025. doi: 10.12201/bmr.202501.00041
wuhangyuan, chenling. Immune Inflammation as a Mediator in the Association Between Gut Microbiota–Related Diet and Depression. 2026. doi: 10.12201/bmr.202603.00082
谢卓, Huang Hongyu, Ai Xiangting, Mo Xiaoyun, Chen Lilan. Prevention and Treatment of Diabetic Foot Based on the Spleen-Stomach and Gut Microbiota Axis. 2026. doi: 10.12201/bmr.202605.00107
Hua Lin. Identification of links between sleepiness and gut microbiota using Mendelian randomization analysis. 2024. doi: 10.12201/bmr.202409.00006
Zhou Jie², Xiao Wei², Sun Zengtao. Understanding the Mechanism and Therapeutic Strategies of the Gut-Lung Axis in Chronic Obstructive Pulmonary Disease from the Perspective of. 2026. doi: 10.12201/bmr.202601.00005
zhang tao. Association Between Gut Microbiota and Liver Cirrhosis in East Asian Populations: A Mendelian Randomization Study. 2024. doi: 10.12201/bmr.202412.00049
liangqiuyun. Mechanisms of Alveolar–Capillary Barrier Injury and Therapeutic Progress in Acute Lung Injury. 2026. doi: 10.12201/bmr.202605.00011
-
ID Submit time Number Download 1 2026-06-15 10.12201/bmr.202607.00026V1
Download -
-
Public Anonymous To author only
Get Citation
Article Metrics
- Read: 71
- Download: 0
- Comment: 0

Login
Register




京公网安备